摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,7-Dimethyl-7-methoxy-octen-(2)-saeure-aethylester | 2218-79-3

中文名称
——
中文别名
——
英文名称
3,7-Dimethyl-7-methoxy-octen-(2)-saeure-aethylester
英文别名
7-Methoxy-3,7-dimethyl-Δ2-octensaeureethylester;7-Methoxy-3,7-dimethyl-oct-2t-en-1-saeure-ethylester;Ethyl 7-methoxy-3,7-dimethyloct-2-enoate;ethyl 7-methoxy-3,7-dimethyloct-2-enoate
3,7-Dimethyl-7-methoxy-octen-(2)-saeure-aethylester化学式
CAS
2218-79-3
化学式
C13H24O3
mdl
——
分子量
228.332
InChiKey
IHOUMNYDOHZGKA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    16
  • 可旋转键数:
    8
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.77
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

点击查看最新优质反应信息

文献信息

  • COMPOSITION FOR USE IN A METHOD FOR LOWERING OF LDL-CHOLESTEROL IN PLASMA
    申请人:ezCol B.V.
    公开号:EP3897677A1
    公开(公告)日:2021-10-27
  • [EN] COMPOSITION FOR USE IN A METHOD FOR LOWERING OF LDL-CHOLESTEROL IN PLASMA<br/>[FR] COMPOSITION À UTILISER DANS UNE MÉTHODE VISANT À ABAISSER LE TAUX PLASMATIQUE DE CHOLESTÉROL LBD
    申请人:EZCOL B V
    公开号:WO2020130813A1
    公开(公告)日:2020-06-25
    The present invention relates to a (pharmaceutical) composition comprising geranyl-geranyl bacteriopheophytin a, phytyl derivative of bacteriopheophytin a, hydroxyspirilloxanthin, rhodovibrin, 3,4- rhodopin, chloroxanthin, rhodopin, spirilloxanthin, 3,4-spirilloxanthin, ubiquinol-10, ubiquinone-9, ubiquinone-10 and rhodoquinone-10, for use in a method for the lowering of LDL-cholesterol in subjects in need thereof. Furthermore, the invention relates to a foodstuff comprising a food supplement, wherein the food supplement has cholesterol-lowering properties and comprises compounds geranyl-geranyl bacteriopheophytin a, phytyl derivative of bacteriopheophytin a, hydroxyspirilloxanthin, rhodovibrin, 3,4- rhodopin, chloroxanthin, rhodopin, spirilloxanthin, 3,4-spirilloxanthin, ubiquinol-10, ubiquinone-9, ubiquinone-10 and rhodoquinone-10. For the pharmaceutical composition and the composition and the food supplement the proviso is that the (pharmaceutical) composition is not, and the compounds are not provided as, a petroleum ether extract of Rhodospirillum rubrum obtainable by extraction of Rhodospirillum rubrum cells with a mixture of petroleum ether with a boiling point of between 60°C and 80°C and methanol comprising sodium chloride, wherein the extract is obtained by extraction for between 10 minutes and 48 hours at between 8°C and 37°C, while mixing the cells with the mixture, and wherein the Rhodospirillum rubrum cells are extracted with the mixture in a volume ratio of between 10:1 and 1:10 of petroleum ether with a boiling point of between 60°C and 80°C and methanol comprising sodium chloride. Furthermore, the (pharmaceutical) composition and compounds are not comprising or provided as whole R.rubrum cells or as a membrane fraction of R.rubrum.
  • Total Synthesis of Spirilloxanthin, Dehydrolycopene, and 1,1'-Dihydroxy-1,2,1',2'-tetrahydrolycopene<sup>1</sup>
    作者:Joseph D. Surmatis、Alfred Ofner
    DOI:10.1021/jo01045a057
    日期:1963.10
查看更多